Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
AMYLIN PHARMACEUTICALS INC (AMLN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2012 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/25/2012 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
04/09/2012 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
04/04/2012 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
01/25/2010 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
05/14/2009 SC 13D/A Carl Icahn has filed a Schedule 13D for Amylin Pharmaceuticals, Inc.
04/30/2009 SC 13D/A Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
04/22/2009 SC 13D/A Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
04/21/2009 SC 13D/A Carl Icahn has filed a Schedule 13D for Amylin Pharmaceuticals, Inc.
04/15/2009 SC 13D/A Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
01/30/2009 SC 13D/A Carl Icahn reports a 8.8% stake in Amylin Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy